Status:
UNKNOWN
Effect of Glycopyrrolate and Atropine on Catheter-Related Bladder Discomfort
Lead Sponsor:
Seoul National University Hospital
Conditions:
Catheter Site Discomfort
Complications
Eligibility:
All Genders
19-80 years
Phase:
NA
Brief Summary
We want to evaluate the efficacy of the glycopyrrolate and atropine for the prevention of catheter-related bladder discomfort.
Detailed Description
The mechanism of catheter-related bladder discomfort is thought to be related to the muscarinic receptor. The adjuncts to reversal agents such as glycopyrrolate and atropine are known to block the mus...
Eligibility Criteria
Inclusion
- Patients scheduled for transurethral bladder excision under general anesthesia
- ASA I-III
Exclusion
- Foley catheter less than 18 Fr.
- Patients with obstruction of urinary tract
- Patients with neurogenic bladder
- Patients with severe obesity
- Patients with neurologic disorder
- Patients with chronic pain
- Patients with allergic history to atropine or glycopyrrolate
Key Trial Info
Start Date :
September 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2015
Estimated Enrollment :
76 Patients enrolled
Trial Details
Trial ID
NCT02228473
Start Date
September 1 2014
End Date
March 1 2015
Last Update
October 28 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University of Hospital
Seoul, Korea, Republic of, South Korea